Precipio Inc (PRPO)

[MONEYMADE]

Transgenomic Launches EGFR CLIA Test That Accurately Detects Key Mutations in Solid and Liquid Patient Samples Using Multiplexed ICE COLD-PCR™
EGFR Tests for Lung and Colon Cancer Are First of Series of CLIA Mutation Detection Tests that Leverage Multiplexed ICE COLD-PCR’s Outstanding Accuracy and Sensitivity and Its Ability to Work with Multiple Patient Sample Types
2015 ASCO Study Abstract Confirms Clinical Utility of Expanded Screening of KRAS and NRAS Genes in Colorectal Cancer Patients Using Transgenomic’s CRC RAScan™ Companion Diagnostic Test
Learn More about Transgenomic’s Expertise in Cancer Patient Testing and Its New Ultra-Sensitive MX-ICP CLIA Mutation Testing at ASCO Booth 12071

http://finance.yahoo.com/news/transgenomic-launches-egfr-clia-test-111500406.html

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=114176717